Novo’s Ozempic, Wegovy Targeted in Second Round of IRA Drug Price Negotiations

Drugmakers will have until the end of February to decide whether they want to participate in the second round of Medicare negotiations or not. CMS has until June 1 to send an initial offer for the adjusted prices.

Scroll to Top